Positive News SentimentPositive NewsNASDAQ:YMAB Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History $5.15 -0.20 (-3.74%) (As of 10:15 AM ET) Add Compare Share Share Today's Range$5.12▼$5.3950-Day Range$4.86▼$6.2952-Week Range$2.70▼$15.89Volume15,031 shsAverage Volume410,578 shsMarket Capitalization$224.64 millionP/E RatioN/ADividend YieldN/APrice Target$12.63 ChartProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Y-mAbs Therapeutics Stock Price Performance5 Day Performance-7.71%1 Month Performance-2.65%3 Month Performance-22.44%6 Month Performance-9.65%Year-To-Date Performance+5.53%1 Year Performance-61.22% Receive YMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address YMAB Stock Chart for Tuesday, October, 3, 2023 YMAB Chart by TradingView Y-mAbs Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/02/2023$5.45$5.35-1.83%$5.53$5.15166,434 shs$233.37 million09/29/2023$5.58$5.45-2.33%$5.86$5.36270,832 shs$237.73 million09/28/2023$5.77$5.58-3.29%$5.82$5.38203,674 shs$243.40 million09/27/2023$5.35$5.77+7.85%$5.79$5.3597,736 shs$251.69 million09/26/2023$5.28$5.35+1.33%$5.56$5.23167,488 shs$233.37 million09/25/2023$5.22$5.28+1.15%$5.37$5.10144,606 shs$230.31 million Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 09/22/2023$5.09$5.22+2.55%$5.26$5.07116,656 shs$227.70 million09/21/2023$5.19$5.09-1.93%$5.21$5.0191,314 shs$222.03 million09/20/2023$5.23$5.19-0.76%$5.38$5.1286,643 shs$226.39 million09/19/2023$5.07$5.23+3.16%$5.43$4.9497,664 shs$228.13 million09/18/2023$4.99$5.07+1.60%$5.12$4.9587,268 shs$221.15 million09/15/2023$4.99$4.99$5.08$4.79263,105 shs$217.66 million09/14/2023$4.96$4.99+0.71%$5.19$4.80123,635 shs$216.14 million09/13/2023$5.01$4.96-1.10%$5.21$4.88128,118 shs$216.14 million09/12/2023$5.17$5.01-3.09%$5.18$4.97124,943 shs$218.54 million09/11/2023$5.07$5.17+1.97%$5.28$4.9997,304 shs$225.52 million09/08/2023$5.01$5.07+1.20%$5.24$4.91101,405 shs$221.15 million09/07/2023$4.86$5.01+3.09%$5.03$4.75183,688 shs$218.54 million09/06/2023$4.92$4.86-1.22%$5.01$4.74162,725 shs$211.99 million09/05/2023$5.29$4.92-6.99%$5.37$4.84177,151 shs$214.61 million09/04/2023$5.29$5.29$5.34$4.96141,000 shs$230.75 million09/01/2023$5.07$5.29+4.34%$5.34$4.96141,077 shs$230.75 million08/31/2023$5.39$5.07-5.94%$5.48$5.0598,660 shs$221.15 million08/30/2023$5.51$5.39-2.18%$5.63$5.34106,868 shs$235.11 million08/29/2023$5.45$5.51+1.10%$5.65$5.38108,068 shs$240.35 million08/28/2023$5.56$5.45-1.98%$5.61$5.34116,979 shs$237.73 million08/25/2023$5.71$5.56-2.63%$5.77$5.44128,260 shs$242.53 million08/24/2023$6.07$5.71-5.93%$6.08$5.5093,472 shs$249.07 million08/23/2023$6.29$6.07-3.50%$6.51$6.04169,251 shs$264.77 million08/22/2023$6.13$6.29+2.61%$6.34$5.74201,127 shs$274.37 million08/21/2023$5.63$6.13+8.88%$6.20$5.48312,389 shs$267.39 million08/18/2023$5.41$5.63+4.07%$5.69$5.23192,932 shs$245.58 million08/17/2023$5.50$5.41-1.64%$5.54$5.18265,980 shs$235.98 million08/16/2023$5.70$5.50-3.51%$5.71$5.43283,727 shs$239.91 million08/15/2023$5.62$5.70+1.42%$5.71$5.31375,323 shs$248.63 million08/14/2023$5.55$5.62+1.26%$5.67$4.60587,099 shs$245.14 million08/11/2023$6.16$5.55-9.90%$6.20$5.22248,877 shs$242.42 million08/10/2023$5.84$6.16+5.48%$6.25$5.85222,270 shs$269.07 million08/09/2023$5.73$5.84+1.92%$5.94$5.66152,097 shs$255.09 million08/08/2023$5.66$5.73+1.24%$6.15$5.57186,583 shs$250.29 million08/07/2023$5.62$5.66+0.71%$5.67$5.21243,294 shs$247.23 million08/04/2023$5.50$5.62+2.18%$5.83$5.50131,250 shs$245.48 million08/03/2023$5.59$5.50-1.61%$5.77$5.49164,047 shs$240.23 million08/02/2023$5.85$5.59-4.44%$5.91$5.56208,876 shs$244.17 million08/01/2023$6.09$5.85-3.94%$6.18$5.83165,932 shs$255.53 million07/31/2023$6.25$6.09-2.56%$6.51$5.85944,907 shs$266.01 million07/28/2023$6.17$6.25+1.30%$6.40$6.2498,507 shs$273 million07/27/2023$6.21$6.17-0.64%$6.40$6.06161,745 shs$269.51 million07/26/2023$6.09$6.21+1.97%$6.36$6.10104,622 shs$271.25 million07/25/2023$6.27$6.09-2.87%$6.42$6.02197,445 shs$266.01 million07/24/2023$6.58$6.27-4.71%$6.70$6.21161,890 shs$273.86 million07/21/2023$6.57$6.58+0.23%$6.85$6.55264,240 shs$287.40 million07/20/2023$7.04$6.57-6.75%$7.12$6.55137,940 shs$286.75 million07/19/2023$7.23$7.04-2.63%$7.44$6.98142,737 shs$307.49 million07/18/2023$7.17$7.23+0.84%$7.47$7.1587,255 shs$315.81 million07/17/2023$7.09$7.17+1.13%$7.33$6.91145,519 shs$313.19 million07/14/2023$7.07$7.09+0.28%$7.10$6.8689,854 shs$309.69 million07/13/2023$7.15$7.07-1.12%$7.27$7.05113,753 shs$308.82 million07/12/2023$6.96$7.15+2.73%$7.45$7.11169,525 shs$312.31 million07/11/2023$6.78$6.96+2.65%$7.00$6.64157,187 shs$304.01 million07/10/2023$6.44$6.78+5.28%$6.95$6.40194,516 shs$296.15 million07/07/2023$6.22$6.44+3.54%$6.64$6.18284,206 shs$281.30 million07/06/2023$6.82$6.22-8.80%$6.75$6.21302,923 shs$271.69 million07/05/2023$6.64$6.82+2.71%$6.98$6.50184,074 shs$297.90 million07/04/2023$6.64$6.64$6.79$6.55103,671 shs$290.02 million07/03/2023$6.79$6.64-2.21%$6.78$6.55103,671 shs$290.04 million Related Companies: FHTX Stock Chart ATXS Stock Chart NVCT Stock Chart IVA Stock Chart ENTA Stock Chart LFCR Stock Chart KMDA Stock Chart VSTM Stock Chart IMRX Stock Chart GBIO Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.